Rocket Lab Stock Falls ~12% as Neutron Launch Slips to 2027
Rocket Lab Corp (RKLB) shares fell 12.08% after announcing Neutron rocket's debut is delayed to 2027. The company cited manufacturing issues with propellant tanks. Despite the delay, Rocket Lab's revenue grew 62% YoY to $234.066M in Q2 2026, with losses narrowing. The market reaction appears specific to Neutron's delay, not broader business concerns.
How this was made

The 30-second read
Why it matters
The announcement triggered a sharp sell‑off, indicating the market priced in the delay risk. No immediate short‑interest surge suggests the move was driven by long holders exiting.
Market read
The news directly caused a 12% intraday decline, making it a primary market mover for RKLB.
What to watch
Short‑term cash flow from existing contracts and potential cost‑cutting measures are not reflected in the price drop.
Background
Rocket Lab's Neutron program has faced multiple schedule slips, now pushed to 2027, while its core Electron launch business shows solid revenue growth.
Ticker impact
Rocket Lab announced its Neutron launch is delayed to 2027, causing the stock to drop 12% in a day.
likely continued downside as investors reassess revenue timeline for Neutron.
The 12% drop reflects immediate market reaction; no offsetting positive news was presented.
Market effects
Highlights execution risk for small launch providers and may benefit competitors like SpaceX in the medium‑lift market.
Limited to U.S. small‑cap and aerospace investors.
Modest; primarily affects niche space‑launch sector.
Counterpoint
If Rocket Lab's existing Electron business continues strong revenue growth, the stock could rebound once the Neutron timeline stabilises.
Key entities
- companyRocket Lab Corp
U.S. listed aerospace company (NASDAQ: RKLB) developing the Neutron medium‑lift rocket.